Extraordinary General Meeting of Shareholders (EGM) - September 25, 2023 at 14:00 CEST
Click here to rewatch the webcast
At the Extraordinary Meeting of Shareholders on September 25, 2023, it will be proposed to appoint Dr. Richard Peters as Non-Executive Director of Pharming Group N.V. Dr. Peters will become the new Chair of the Board of Directors following his appointment as Non-Executive Director. In the Explanatory Notes, released on August 14, 2023 (see below), a resume of Dr. Richard Peters has been included. In his resume, it is mentioned that he currently serves as, inter alia, Non-Executive Director for Aprea Therapeutics (NASDAQ: APRE). For the sake of completeness, we hereby inform you that, as per August 24, 2023, Aprea Therapeutics appointed Dr. Peters as Chairman of its Board of Directors. This will not change the binding nomination and proposal to appoint him as Non-Executive Director of Pharming Group N.V.
Annual General Meeting of Shareholders (AGM) - May 17, 2023 at 14:00 CEST
Click here to rewatch the webcast.
We have uploaded the draft minutes of the Annual General Meeting of Shareholders held on May 17, 2023.
In accordance with the Dutch Corporate Governance Code, shareholders may send comments on the draft minutes within three months following the publication of the draft, i.e. by November 17, 2023 at 17.00 CET at the latest. Please send these comments to the following e-mail address: email@example.com. Thereafter, the comments will be considered, and the minutes will be adopted in final form.
Annual General Meeting of Shareholders (AGM) - May 22, 2019